Opens in a new tab or window In August, the FDA approved another first-line treatment option for patients with EGFR-mutant non-small cell lung cancer (NSCLC): the third-generation EGFR tyrosine ...

Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary b ...

In contrast, when the disease advances to stage III or IV, the treatment shifts towards chemotherapy or radiotherapy. As the most prevalent type of lung cancer, non-small cell lung cancer (NSCLC) is ...

The most common types of lung cancer are non-small cell lung cancer (NSCLC)—which accounts for 80 ... A 2019 study in the Journal of Thoracic Oncology found that low-dose computerized tomography (CT) ...

Its tumor cells look flat under a microscope. Combined small cell carcinoma: Combined small cell carcinoma involves tumors comprised of small cell carcinoma cells and non-small ... test for lung ...

Results: Six (1.3%) NCNs of ⩾10 mm were detected of which one (0.23%) had non-small cell lung cancer stage 1; 145 NCNs of <10 mm were detected in 87 (19.4%) subjects. Mediastinal masses were detected ...

The INTerpath-009 trial will investigate an individualized neoantigen therapy plus Keytruda in patients with non-small cell lung cancer post-surgery whose disease didn't fully respond to prior ...

Small cell lung cancer (SCLC) often responds well to initial treatment before later relapsing. Researchers are continuing to investigate new treatments, such as targeted therapy and immunotherapy ...

2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 ... Scientists Discover That Special ...

There are two main types of lung cancer. Most lung cancers are called non-small cell lung cancer (NSCLC). This group includes: adenocarcinoma squamous cell carcinoma large cell carcinoma ALK ...